Epidemiyoloji, Risk Faktörleri ve Korunma Stratejileri

Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2024;74(3):229-63.

Siegel RL, Kratzer TB, Giaquinto AN, et al. Cancer statistics, 2025. Ca. 2025;75(1):10-45.

Smolarz B, Nowak AZ, Romanowicz H. Breast cancer—epidemiology, classification, pathogenesis and treatment (review of literature). Cancers. 2022;14(10):2569.

Bellanger M, Zeinomar N, Tehranifar P, et al. Are global breast cancer incidence and mortality patterns related to country-specific economic development and prevention strategies? Journal of global oncology. 2018.

Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA: a cancer journal for clinicians. 2022;72(1).

Lima SM, Kehm RD, Terry MB. Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns. EClinicalMedicine. 2021;38.

Sha R, Kong X-m, Li X-y, et al. Global burden of breast cancer and attributable risk factors in 204 countries and territories, from 1990 to 2021: results from the Global Burden of Disease Study 2021. Biomarker Research. 2024;12(1):87.

Cancer CGoHFiB. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. The lancet oncology. 2012;13(11):1141-51.

Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. bmj. 2020;371.

Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. Jama. 2017;317(23):2402-16.

DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019. CA: a cancer journal for clinicians. 2019;69(6):438-51.

Socolov D, Anghelache I, Ilea C, et al. Benign breast disease and the risk of breast cancer in the next 15 years. Rev Med Chir Soc Med Nat Iasi. 2015;119(1):135-40.

Hauptmann M, Daniels RD, Cardis E, et al. Epidemiological studies of low-dose ionizing radiation and cancer: summary bias assessment and meta-analysis. JNCI Monographs. 2020;2020(56):188-200.

Torre LA, Islami F, Siegel RL, et al. Global cancer in women: burden and trends. Cancer epidemiology, biomarkers & prevention. 2017;26(4):444-57.

Obeagu EI, Obeagu GU. Breast cancer: A review of risk factors and diagnosis. Medicine. 2024;103(3):e36905.

Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body fatness and cancer—viewpoint of the IARC Working Group. New England journal of medicine. 2016;375(8):794-8.

Gallagher EJ, LeRoith D. Obesity and diabetes: the increased risk of cancer and cancer-related mortality. Physiological reviews. 2015;95(3):727-48.

Hormones TE, Group BCC. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. The lancet oncology. 2010;11(6):530-42.

Jardé T, Perrier S, Vasson M-P, et al. Molecular mechanisms of leptin and adiponectin in breast cancer. European journal of cancer. 2011;47(1):33-43.

Iyengar NM, Gucalp A, Dannenberg AJ, et al. Obesity and cancer mechanisms: tumor microenvironment and inflammation. Journal of clinical oncology. 2016;34(35):4270-6.

Cao Y. Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nature reviews Drug discovery. 2010;9(2):107-15.

Rodríguez-Miguel C, Moral R, Escrich R, et al. The role of dietary extra virgin olive oil and corn oil on the alteration of epigenetic patterns in the rat DMBA-induced breast cancer model. PLoS One. 2015;10(9):e0138980.

Buja A, Pierbon M, Lago L, et al. Breast cancer primary prevention and diet: an umbrella review. International journal of environmental research and public health. 2020;17(13):4731.

Scoccianti C, Cecchini M, Anderson AS, et al. European Code against Cancer 4th Edition: Alcohol drinking and cancer. Cancer epidemiology. 2016;45:181-8.

Kolak A, Kamińska M, Sygit K, et al. Primary and secondary prevention of breast cancer. Annals of Agricultural and environmental Medicine. 2017;24(4).

Dibden A, Offman J, Duffy SW, et al. Worldwide review and meta-analysis of cohort studies measuring the effect of mammography screening programmes on incidence-based breast cancer mortality. Cancers. 2020;12(4):976.

Duffy SW, Vulkan D, Cuckle H, et al. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. The Lancet Oncology. 2020;21(9):1165-72.

Force UPST, Nicholson WK, Silverstein M, et al. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Jama. 2024;331(22):1918-30.

Network NCC. Breast cancer screening and diagnosis. Version 2.2025. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)2025.

Loibl S, André F, Bachelot T, et al. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology. 2024;35(2):159-82.

Monticciolo DL, Malak SF, Friedewald SM, et al. Breast cancer screening recommendations inclusive of all women at average risk: update from the ACR and Society of Breast Imaging. Journal of the American College of Radiology. 2021;18(9):1280-8.